Literature DB >> 21416062

A microRNA contribution to aberrant Ras activation in gastric cancer.

Emily Ky Lam, Xian Wang, Vivian Y Shin, Shengjie Zhang, Helen Morrison, Jie Sun, Enders Ko Ng, Jun Yu, Hongchuan Jin.   

Abstract

Oncogenic Ras mutations are rare in gastric cancer, indicating that other mechanisms may be responsible for aberrant Ras activation in this type of cancer. Ezrin is critical to Ras activation by remodeling cortical actin cy-toskeleton. In this study, we aimed to illustrate the relevance and regulation of ezrin in gastric cancer. Ezrin was upregulated in gastric cancer cells. Ezrin siRNA inhibited Ras activation, cell growth and cell migration. Ezrin overex-pression was correlated with a poor outcome of gastric cancer patients (n=150, p<0.01). Cox regression analysis revealed a significant value of ezrin expression in prognosis prediction of gastric cancer (relative risk: 2.37, 95% confidence interval: 1.24-4.56, p<0.01). MiR-204, which was predicted to target ezrin, was downregulated in gastric cancer cells and gastric carcinomas (n=22, p<0.01). MiR-204 inhibited ezrin expression, Ras activation, cell growth and cell migration. Importantly, miR-204 suppressed the expression of luciferase controlled by wild-type but not mutated ezrin 3'-UTR. In conclusion, ezrin is important to Ras activation in gastric cancer. Its upregulation is an independent prognosis prediction factor for gastric cancer. By contributing to ezrin upregulation, miR-204 downregulation represents a novel mechanism for aberrant Ras activation in gastric carcinogenesis.

Entities:  

Keywords:  Ezrin; Ras; gastric cancer; miR-204

Year:  2011        PMID: 21416062      PMCID: PMC3056566     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  29 in total

Review 1.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

Review 2.  The functions of animal microRNAs.

Authors:  Victor Ambros
Journal:  Nature       Date:  2004-09-16       Impact factor: 49.962

Review 3.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

4.  Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients.

Authors:  T N Basu; D H Gutmann; J A Fletcher; T W Glover; F S Collins; J Downward
Journal:  Nature       Date:  1992-04-23       Impact factor: 49.962

5.  Tumorigenic transformation by CPI-17 through inhibition of a merlin phosphatase.

Authors:  Hongchuan Jin; Tobias Sperka; Peter Herrlich; Helen Morrison
Journal:  Nature       Date:  2006-08-03       Impact factor: 49.962

6.  RAS is regulated by the let-7 microRNA family.

Authors:  Steven M Johnson; Helge Grosshans; Jaclyn Shingara; Mike Byrom; Rich Jarvis; Angie Cheng; Emmanuel Labourier; Kristy L Reinert; David Brown; Frank J Slack
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

Review 7.  Hyperactive Ras in developmental disorders and cancer.

Authors:  Suzanne Schubbert; Kevin Shannon; Gideon Bollag
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

8.  An extensive class of small RNAs in Caenorhabditis elegans.

Authors:  R C Lee; V Ambros
Journal:  Science       Date:  2001-10-26       Impact factor: 47.728

9.  Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.

Authors:  Hongchuan Jin; Xian Wang; Jianming Ying; Ada H Y Wong; Yan Cui; Gopesh Srivastava; Zhong-Ying Shen; En-Min Li; Qian Zhang; Jie Jin; Sabine Kupzig; Anthony T C Chan; Peter J Cullen; Qian Tao
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-18       Impact factor: 11.205

10.  Infrequent ras mutation in human stomach cancers.

Authors:  M Koshiba; O Ogawa; T Habuchi; S Hamazaki; T Shimada; R Takahashi; T Sugiyama
Journal:  Jpn J Cancer Res       Date:  1993-02
View more
  39 in total

Review 1.  MicroRNAs in tumorigenesis, metastasis, diagnosis and prognosis of gastric cancer.

Authors:  C Jiang; X Chen; M Alattar; J Wei; H Liu
Journal:  Cancer Gene Ther       Date:  2015-05-22       Impact factor: 5.987

2.  Transformer 2β and miR-204 regulate apoptosis through competitive binding to 3' UTR of BCL2 mRNA.

Authors:  Y Kuwano; K Nishida; K Kajita; Y Satake; Y Akaike; K Fujita; S Kano; K Masuda; K Rokutan
Journal:  Cell Death Differ       Date:  2014-10-24       Impact factor: 15.828

3.  MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.

Authors:  Shao-Qian Cui; Huan Wang
Journal:  Tumour Biol       Date:  2015-04-09

4.  Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.

Authors:  Shengjie Zhang; Tingting Jiang; Lifeng Feng; Jie Sun; Haiqi Lu; Qinchuan Wang; Min Pan; Dongsheng Huang; Xian Wang; Linbo Wang; Hongchuan Jin
Journal:  J Mol Med (Berl)       Date:  2012-03-06       Impact factor: 4.599

5.  MiR-330-3p inhibits gastric cancer progression through targeting MSI1.

Authors:  Aoran Guan; Hui Wang; Xun Li; Hui Xie; Ruotian Wang; Yankun Zhu; Ruhong Li
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

6.  MicroRNA-204 critically regulates carcinogenesis in malignant peripheral nerve sheath tumors.

Authors:  Meng Gong; Junrong Ma; Mi Li; Mingliang Zhou; Janet M Hock; Xijie Yu
Journal:  Neuro Oncol       Date:  2012-06-19       Impact factor: 12.300

Review 7.  Non-Coding RNAs in Endometrial Physiopathology.

Authors:  Alessandro La Ferlita; Rosalia Battaglia; Francesca Andronico; Salvatore Caruso; Antonio Cianci; Michele Purrello; Cinzia Di Pietro
Journal:  Int J Mol Sci       Date:  2018-07-20       Impact factor: 5.923

8.  Comprehensive MicroRNA expression profiling identifies novel markers in follicular variant of papillary thyroid carcinoma.

Authors:  Matthias Dettmer; Aurel Perren; Holger Moch; Paul Komminoth; Yuri E Nikiforov; Marina N Nikiforova
Journal:  Thyroid       Date:  2013-09-19       Impact factor: 6.568

9.  Helicobacter, Inflammation, and Gastric Cancer.

Authors:  Antonia R Sepulveda
Journal:  Curr Pathobiol Rep       Date:  2013-03

10.  MicroRNA-204, a direct negative regulator of ezrin gene expression, inhibits glioma cell migration and invasion.

Authors:  Jie Mao; Mengying Zhang; Min Zhong; Yingying Zhang; Kun Lv
Journal:  Mol Cell Biochem       Date:  2014-07-24       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.